Cue 16 Reflections

  1. Cue 16 Reflections Circle
  2. Cue 16 Reflections Youtube

Technical Analysis for CUE - Cue Biopharma, Inc.

Johns Model of reflection Johns model is based on five cue questions which enable you to break down your experience and reflect on the process and outcomes. John (1995) used seminal work by Carper (1978) as the basis for his model exploring aesthetics, personal knowing, ethics and empirics and then encouraging the reflective practitioner to. Step 1: Locate the reflection of the 8 ball. The rail (red line) is equidistant from the 8 ball and the reflection. Step 2: Draw a line from the side pocket to the reflection. We now know the line along which the 8 ball should travel in order to go into the side pocket. The intersection of the red and blue lines is the location of point P.

Grade Last Price% ChangePrice Change
CUE closed up 2.55 percent on Friday, January 22, 2021, on 86 percent of normal volume.
ADX Long Term Intermediate Term Short Term
Weak or AbsentDown Up Up
Historical CUE trend table...
DateAlert NameType% Chg
Bullish Swing Setup0.00%
Bullish Swing Setup2.55%
Range Contraction-2.49%
Cue Older End-of-Day Signals for CUE ...

Recent Intraday Alerts --Get these alerts pushed to you via ourMobile App

Trending on StockTwits1 day ago
Up 3%2 days ago
Up 2%2 days ago
60 Minute Opening Range Breakout2 days ago
10 DMA Support2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Cue 16 Reflections Circle

Let us help you stay on top of your investments. We will alert you to important technical developments on yourportfolio & watchlist.
Configure default chart indicators
CUE Chartby TradingView
Basic chart:
  • Earnings date:11/17/2020
Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
Keywords:BiotechnologyBiopharmaceuticalCancerLife SciencesPharmaceutical IndustryImmune SystemPharmacyCancersMedicationSpecialty DrugsAutoimmunityImmune DisordersAutoimmune Disorders
IndicatorBull CaseNeutral / HoldBear Case
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Jan 9How Much Are Cue Biopharma, Inc. (NASDAQ:CUE) Insiders Spending On Buying Shares?
Jan 7Cue Biopharma: CUE-101's Phase 1 Promising Progress, 1 New IND Expected, Funding Until Q2 2022
Dec 16Is CUE A Good Stock To Buy Now?
Dec 7Do Options Traders Know Something About Cue Biopharma (CUE) Stock We Don't?
Dec 110 Health Care Stocks With Unusual Options Alerts In Today's Session
Nov 25News Flash: Analysts Just Made A Substantial Upgrade To Their Cue Biopharma, Inc. (NASDAQ:CUE) Forecasts
Nov 24Benzinga's Top Upgrades, Downgrades For November 24, 2020
Nov 23Cue Biopharma to Present at the Piper Sandler 32nd Annual Healthcare Conference
Nov 20Cue Biopharma (CUE) Investor Presentation - Slideshow
Nov 19Cue Biopharma Extends Research Collaboration for the Development of Immuno-STAT Biologics for the Treatment of Defined Autoimmune Diseases with Merck
See more CUE news...
52 Week High31.69
52 Week Low9.3
Average Volume277,677
200-Day Moving Average18.59
50-Day Moving Average12.95
20-Day Moving Average13.00
10-Day Moving Average13.35
Average True Range0.88
Chandelier Exit (Long, 3ATRs)12.74
Chandelier Exit (Short, 3ATRs)14.54
Upper Bollinger Band14.36
Lower Bollinger Band11.64
Percent B (%b)0.89
MACDSignal Line0.07
Market Cap426.02 Million
Num Shares30.3 Million
Price-to-Earnings (P/E) Ratio-6.40
Pivot Point LevelTraditional / ClassicFibonacciDemarkWoodieCamarilla
Resistance 4 (R4)15.41
Resistance 3 (R3)15.2914.7215.18
Resistance 2 (R2)14.7214.3814.7815.11
Resistance 1 (R1)14.4014.1714.5614.5215.03
Pivot Point13.8313.8313.9213.8913.83
Support 1 (S1)13.5113.4913.6713.6313.11
Support 2 (S2)12.9413.2813.0013.03
Support 3 (S3)12.6212.9412.96
Support 4 (S4)12.74
You must be logged in to access watchlists

Cue 16 Reflections Youtube

You must be logged in to access portfolios